$3250 | Single User
$4650 | Site License
$5650 | Global License

Point of Care (POC) Diagnostics Market, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Urinalysis, Fertility, Cardiac Markers, Infectious Diseases, and others), By Disease Condition And Geography (North America, Europe, Asia Pacific, And RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270583 | In Stock
Related Topics: Abbott , Chemistry , COVID , Drug , FDA , Fertility , Healthcare , Infectious Disease , Medical , Products , Roche , Services

Introduction

REPORT HIGHLIGHT

The point of care (POC) diagnostics market is estimated to represent a global market of USD 16,237 million by 2019 with growth rate of 7.1%.

Point of care testing is a medical tool, designed to perform outside the physical facilities such as clinical laboratories. These tests are primarily used to diagnose various chronic disease conditions such as diabetes, cardiovascular disorders, infectious diseases and others.

Market Dynamics

Point of care diagnostics market is primarily driven by the rising demand for home healthcare coupled with continuous aging population across the world. World Health Organization (WHO) has projected that aging population, over 60 years, will be doubled, from 12% (2015) to 22% (2050). Similarly, According to the Population Reference Bureau (PRB), geriatric population (over 65 years) is projected to double in America by the next few years. Considering these facts, several initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models which will surge in demand for POC diagnostics, augmenting the market growth.

Additionally, favorable regulatory initiatives, aimed at promoting a point of care diagnosis is anticipated to serve the industry as a high impact rendering driver. For example, the U.S. government (U.S. FDA) introduced CLIA (clinical laboratory improvement amendments) in partnership with the Centres for Medicare & Medicaid Services (CMS) and the Centre for Disease Control (CDC). This regulation aims to conduct laboratory inspection and enforce regulatory compliances in order to assure quality laboratory testing, expected to boost usage rates of POC during the forecast period. Furthermore, increasing funding, from organizations such as National Institute of Biomedical Imaging and Bioengineering, the U.S. Department of Defence (DOD), and the Bill and Melinda Gates Foundation, for the development of point of care diagnostics support the industry growth to great extent. Introduction of mobile applications such as cobas infinity point-of-care (Roche Diagnostics), growing demand for point of care diagnostics, and rising investment by companies is expected to spur the growth in the coming years. However, the regulatory framework for approval process has been the most critical restraining factor for the industry growth.

Products Takeaway

In terms of products, the market is categorized as Glucose Testing, Hb1Ac Testing, Coagulation, Urinalysis, Fertility, Cardiac Markers, Infectious Diseases, Hematology, Decentralized Clinical Chemistry, Ambulatory Chemistry, Drug Abuse Testing, and others. Among which, glucose testing and Hb1Ac testing accounted for the largest share of the global market. Collectively, these segments achieved around USD 9.5 billion in 2019 and are anticipated to dominate the industry. However, cardiac markers segment is projected to grow with the highest growth rate over the forecast period.

COVID-19 Impact and Recovery Analysis

The novel COVID-19 has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. However, this market is positively affected due to this outbreak. In April 2020, the World Health Organization (WHO) advised to use use of point-of-care immunodiagnostic tests for COVID-19 patients. This report presented by AnalystView Market Insights contains a thorough analysis of the pre and post COVID-19 market scenarios. The report includes all the recent development and changes recorded during the COVID-19 outbreak and comprehends the analysis of top performer segments and marginal growth segment in blood culture test sector.

Regional Takeaway

Regionally the market is classified in North America, Europe, Asia Pacific and Rest of the world. Increasing population base with cardio metabolic disorders and diabetes is expected to stimulate the market growth in North America and Europe. According to the Centers for Disease Control and Prevention (CDC), over 31% of population in the U.S. was suffering from bad cholesterol or LDL in 2012. On other side, large patient base coupled with the growing demand for in-vitro diagnostics in developing regions such as India and China provides a healthy platform for the POC growth in developing regions.

Key Vendor Takeaway

Companies such as Danaher Corporation, Roche Diagnostics, Alere Inc., bioMerieux, Abbott Laboratories, and Siemens Healthcare are profiled in the report. Strategic merger and acquisitions and the introduction of new products helped companies to capture significant revenue share. For example, Alere, Inc., one of the leader in rapid point of care diagnosis testing, hold strong distribution channel across the world in order to supply its products to laboratories, physicians’ clinics, and hospitals. This company also operates via third-party distributors for selling its products. Key distributor partners of the company include Henry Schein Medical, McKesson, NDC, Cardinal Health, Medline, Merck, Menearini Diagnostics, and Orion Diagnostica Oy.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

Table of Contents
for Point of Care (POC) Diagnostics Market, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Urinalysis, Fertility, Cardiac Markers, Infectious Diseases, and others), By Disease Condition And Geography (North America, Europe, Asia Pacific, And RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. POC LIPID DIAGNOSTICS MARKET OVERVIEW

    1.1. Study Scope

    1.2. Base Year

    1.3. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. POC LIPID DIAGNOSTICS KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trend

    4. POC LIPID DIAGNOSTICS INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Regulatory Framework Analysis

    4.3. Market Attractiveness Analysis

    4.4. Value Chain Analysis

    5. POC LIPID DIAGNOSTICS MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. POC LIPID DIAGNOSTICS MARKET – BY APPLICATION:

    6.1. Overview

    6.2. Hyperlipidemia

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.3. Hypertriglyceridemia

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.4. Familial hypercholesterolemia

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.5. Hyperlipoproteinemia

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.6. Tangier disease

    6.6.1. Overview

    6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.7. Others

    6.7.1. Overview

    6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7. POC LIPID DIAGNOSTICS MARKET – BY INSTRUMENT:

    7.1. Overview

    7.2. Roche Cobas b 101

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.3. Abaxis Piccolo Xpress

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.4. Roche Reflotron

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.5. Alere Cholestech LDX

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.6. Alere Afinion

    7.6.1. Overview

    7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.7. Samsung LABGEO PT10

    7.7.1. Overview

    7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.8. Cardiocheck

    7.8.1. Overview

    7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8. POC LIPID DIAGNOSTICS MARKET– BY GEOGRAPHY

    8.1. Introduction

    8.2. North America

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.3. U.S.

    8.2.3.1. Overview

    8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.4. Canada

    8.2.4.1. Overview

    8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3. Europe

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.3. France

    8.3.3.1. Overview

    8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.4. Germany

    8.3.4.1. Overview

    8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.5. Rest of Europe

    8.3.5.1. Overview

    8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4. Asia Pacific (APAC)

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.3. China

    8.4.3.1. Overview

    8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.4. India

    8.4.4.1. Overview

    8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.5. Rest of APAC

    8.4.5.1. Overview

    8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5. Rest of the World

    8.5.1. Overview

    8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.3. Latin America

    8.5.3.1. Overview

    8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.4. Middle East and Africa

    8.5.4.1. Overview

    8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9. KEY VENDOR ANALYSIS

    9.1. Samsung

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.2. Roche Diagnostics

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.3. Alere

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.4. Abaxis, Inc.

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.5. Bio-Rad Laboratories

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    *Client can request additional company profiling as per specific requirements

    10. 360 DEGREE ANALYSTVIEW

    11. APPENDIX

    11.1. Research Methodology

    11.2. Abbreviations

    11.3. Disclaimer

    11.4. Contact Us

List Of Tables
in Point of Care (POC) Diagnostics Market, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Urinalysis, Fertility, Cardiac Markers, Infectious Diseases, and others), By Disease Condition And Geography (North America, Europe, Asia Pacific, And RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global POC Lipid Diagnostics Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Table 10 POC Lipid Diagnostics Market, by Application, 2016 – 2027 (USD Million)

Table 11 POC Lipid Diagnostics Market, by Instruments, 2016 – 2027 (USD Million)

Table 12 POC Lipid Diagnostics Market, by Geography, 2016 – 2027 (USD Million)

Table 13 North America POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 14 U.S. POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 15 Canada POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 16 Europe POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 17 France POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 18 Germany POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 19 Asia Pacific POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 20 China POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 21 India POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 22 Latin America POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 23 MEA POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Point of Care (POC) Diagnostics Market, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Urinalysis, Fertility, Cardiac Markers, Infectious Diseases, and others), By Disease Condition And Geography (North America, Europe, Asia Pacific, And RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methdology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 POC Lipid Diagnostics Market, by Application, 2016 – 2027 (USD Million)

Figure 7 POC Lipid Diagnostics Market, by Instrument, 2016 – 2027 (USD Million)

Figure 8 POC Lipid Diagnostics Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270583 | AV203

Number of Pages

188

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
11 Jul 2016 by Global Data USD $300 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
15 Apr 2016 by Global Data USD $300 More Info
MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
MediPoint: Point of Care Diagnostics - Global Analysis and Market ForecastsSummaryPoint-of-care test...
01 Mar 2016 by Global Data USD $5,995 More Info
Point of Care Diagnostics - Current and Future Players
Point of Care Diagnostics - Current and Future PlayersSummaryThe Point-Of-Care (POC) market is very ...
01 Mar 2016 by Global Data USD $3,500 More Info
Point of Care Diagnostics - US Analysis and Market Forecasts
Point of Care Diagnostics - US Analysis and Market ForecastsSummaryThe US Point-Of-Care (POC) diagno...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - 5EU Analysis and Market Forecasts
Point of Care Diagnostics - 5EU Analysis and Market ForecastsSummaryThe Europe Point-Of-Care (POC) d...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - APAC Analysis and Market Forecasts
Point of Care Diagnostics - APAC Analysis and Market ForecastsSummaryThe Asia-Pacific (APAC) Point-O...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - South American Analysis and Market Forecasts
Point of Care Diagnostics - South American Analysis and Market ForecastsSummaryThe South America Poi...
01 Mar 2016 by Global Data USD $4,450 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
09 Jan 2016 by Global Data USD $300 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Point of Care (POC) Diagnostics Market, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Urinalysis, Fertility, Cardiac Markers, Infectious Diseases, and others), By Disease Condition And Geography (North America, Europe, Asia Pacific, And RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...